IN-VITRO STUDIES OF PREDNISOLONE PRE-FORMULATIONS RELEASED FROM VARIOUS OINTMENT-BASES, FACTORS AFFECTING PENETRATION RATE AND PENETRATED AMOUNT
Abstract
In this pre-formulation study, the effect of individual factors influencing the penetration rate of drugs incorporated in various topical vehicles has been in-vitro investigated. The water poor soluble prednisolone is chosen as a model drug. To increase the dissolution behavior of prednisolone (P), co-precipitates of it with polyvinyl-pyrrolidone25, (P/PVP25-coprs), polyethylene glycol6000, (P/PEG6000-coprs) and adsorbents with Aerosil200 (P/A-200-adsrob) were prepared and in-vitro tested. A significantly increased dissolution in purified water was obtained with the co-precipitate F1, consisting of 10-wt% prednisolone and 90-wt% PEG6000. As F1 was incorporated in various model-vehicles insignificant penetration profile was achieved. This effect was in fact due to the high concentration of PEG6000 in the vehicles, which has increased the bulk viscosity of the ointments, that resulted on the one hand in restricted drug particles movement between the phases and on the other between the external phase and the artificial membrane. In contrast, F2 consisted of 50-wt% Prednisolone and 50-wt.%/ PEG6000-copr, showed a slight increase in drug solubility compared to the corresponding physical mixture as well to pure P. As F2 was incorporated in aqueous emulsifying wool wax-base, (WHES) a greater penetration rate into the synthetic membranes has resulted, and no change in the crystal form of P could be observed throughout the study time period of 70 hours. All other pre-formulations, (prefs) showed negligible increase in the solubility of P. X-ray diffractions studies of prednisolone-PVP25-coprs and those of drug/Aerosil200-adsorbent, indicated changes in the crystal form of P into monohydrate, which probably happened during the co-precipitation and adsorption of the drug and also during the incorporation of the pre-formulations into ointments. This change was specifically due to the very few amount of water present in ethanol 96 %v/v used as solvent for the preparation of the P-co-precipitates and adsorbents (= prefs) and also due to water available in the external phase of all used o/w-emulsions type ointment-bases.
References
2.Rasenack N, Hartenhauer R, Müller BW (2003) Micro-crystals for dissolution rate enhancement of poorly water-soluble drugs. Int. J. Pharm. 254: 137-145.
3.Waters K, Brain K (2002) Dermatological formulations and transdermal systems. In
4.Waters K (ed.) Dermatological and transdermal formulations, Marcel Dekker, New York, p. 401-499
5.Wohlrab W. The influence of urea on the penetration kinetics of topically applied corticosteroids. Acta Derm. Venerol. (Stockh). (1984) 64, 233-238.
6.Shalla W, Bauer, Shaefer H. Beeinflussungsgroessen der penetration von steroidexterna. Aktuelle Dermatol. (1980) 6:3.
7.Pschyrembel, Klinisches Woerterbuch, 259 Auflage; Water de Gruyter Verlag; Berlin/New York; (2002) 1520.
8.Brian Barry, Transdermal drug delivery. In M. E. Aulton, Pharmaceutics, the Science of dosage form design, 2-ed. Churchill-Living-stone, Edinburgh/London/New York, (2002) 499.
9.Neubert R.; Wohlrab W. In-vitro penetration methods for the biopharmaceutical evaluation of topically applied formulations. Acta Pharm. Technol.; 36-4 (1990) 197.
10.Neubert R, Wohlrab W, in skin penetration for controlled drug applications, Rietbrock N, Woodock B, (Eds), Steinkoff Verlag, Darmstadt 1990.
11.H. Friedrich; B. Fussneger; K. Kolter R. Bodmeier; dissolution rate improvement of poorly water-soluble drugs obtained by adsorbing solutions of drugs in hydrophilic solvents onto high surface area carriers. Eur. J. Pham. Biopharm. 62 (2006) 171-177.
12.Fahr F.; Dissertation B; Sektion Pharmazie der MLU/Halle/1984.
13.Neubert R.; Wohlrab W.; CH. Bendas. A multiplayer membrane system for modeling drug penetration into the skin. Int. J. Pharm. 75 (1991) 89.
14.B Poulsen, E Young, M Katz. Effect of topical vehicles composition on the in-vitro release of floucinolone acetonide and its acetate ester. J. Pharm. Sci. 57 (1968) 928-933.
15.Fiedler H. P.; Lexikon der Hilfstoffe Bd. 2 Eidito Contor; Aulendorf; 3-Auflage (1989) 964-997.
16.V. Buehler, Kollidon, PVP for the pharmaceutical Industry; BASF AG; Feinchemie 1999.
17.Pattanaik S.; K. Bhanunik, absorption behavior of polypyrrolidone, Matter Lett. 44 (200) 352.
18.H. H. Rupprecht, B. Kerstiens, H. Teschinger, stability of drugs adsorbed on Silica, Acta Pharm. Technol. 27 (1) (1981) 37.
19.M. Masharraf; C. Nystrom, the effect of particle size and shape on the surface of specific dissolution rate of micronized partially insoluble drugs. Int. J. Pharm. 122 (1995) 35-47.
20.Diallo B.; Dissertation A; FB. Pharmazie der MLU/Halle/S; (1983)
